News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Researchers Note Cautions About Geron Corporation (GERN) Drug Imetelstat


11/11/2013 8:31:25 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

This morning, an abstract containing new data on Geron GERN +3.76%’s drug imetelstat caused shares in the tiny, Menlo Park, Calif., biotechnology company to more than double to $7.78; they fell some, but still ended the day up 44% to $5.20, giving Geron a market capitalization of $670 million. Obviously, excitement around this medicine is high.

Help employers find you! Check out all the jobs and post your resume.

Read at Forbes

comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES